|
|
|
|
|
by aintgonnatakeit
1139 days ago
|
|
The first study has 3 patients. The second study is a little better, but not by much. Both have the same first author. If this were legitimate, some academic medical center in the US would have picked it up. Parkinson’s is a huge target, and this kind of thing makes a career. This is likely on the same level as horse dewormer for COVID. |
|
"Eschew flamebait. Avoid generic tangents."
https://news.ycombinator.com/newsguidelines.html